Veracyte Announces Positive Data From Three Afirma Studies to Be Presented at World Congress on Thyroid Cancer - Business Wire (press release)

Veracyte Announces Positive Data From Three Afirma Studies to Be Presented at World Congress on Thyroid Cancer Business Wire (press release) “Our Afirma GEC has set a new standard of care in thyroid cancer diagnosis, with more than 25 peer-reviewed, published studies demonstrating its performance and clinical utility, and coverage by all leading U.S. health insurers,” said Bonnie Anderson, ... and more »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2tCXrri
via IFTTT